Journal article · 2020
Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment
Gynecologic Oncology, 156(3), 561–567 · Published 22 January 2020 · DOI 10.1016/j.ygyno.2020.01.026
In brief
“Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment” is a 2020 journal article by Laura Jean Havrilesky and 8 co-authors, published in Gynecologic Oncology. OpenAlex counts 34 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 34
- Most cited in
- 2021 (10)
- Field-weighted impact
- 2.08
- References
- 42
- Authors
- 9
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Havrilesky, L. J., Lim, S. L., Ehrisman, J. A., Lorenzo, A., Secord, A. A., Yang, J., Johnson, F. R., González, J. M., & Reed, S. D. (2020). Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment. Gynecologic Oncology, 156(3), 561–567. https://doi.org/10.1016/j.ygyno.2020.01.026
MLA 9
Havrilesky, Laura Jean, et al. “Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment.” Gynecologic Oncology, vol. 156, no. 3, 2020, pp. 561–567. https://doi.org/10.1016/j.ygyno.2020.01.026.
Chicago
Havrilesky, Laura Jean, Stephanie L. Lim, Jessie A. Ehrisman, Amelia Lorenzo, Angeles Alvarez Secord, Jui‐Chen Yang, F. Reed Johnson, Juan Marcos González, and Shelby D. Reed. 2020. “Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment.” Gynecologic Oncology 156 (3): 561–567. https://doi.org/10.1016/j.ygyno.2020.01.026.
Harvard
Havrilesky, L. J. et al. (2020) ‘Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment’, Gynecologic Oncology, 156(3), pp. 561–567. doi:10.1016/j.ygyno.2020.01.026.
IEEE
L. J. Havrilesky et al., “Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment,” Gynecologic Oncology, vol. 156, no. 3, pp. 561–567, 2020, doi: 10.1016/j.ygyno.2020.01.026.
BibTeX
@article{havrilesky2020patient,
title = {{Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment}},
author = {Havrilesky, Laura Jean and Lim, Stephanie L. and Ehrisman, Jessie A. and Lorenzo, Amelia and Secord, Angeles Alvarez and Yang, Jui‐Chen and Johnson, F. Reed and González, Juan Marcos and Reed, Shelby D.},
journal = {Gynecologic Oncology},
year = {2020},
volume = {156},
number = {3},
pages = {561--567},
doi = {10.1016/j.ygyno.2020.01.026},
url = {https://doi.org/10.1016/j.ygyno.2020.01.026}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 3 | |
| 2021 | 10 | |
| 2022 | 4 | |
| 2023 | 6 | |
| 2024 | 1 | |
| 2025 | 5 | |
| 2026 | 5 |
Its field-weighted citation impact is 2.08: it has been cited 2.08 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- ovarian cancer
- maintenance therapy
- PARP inhibitors
- patient preferences
- treatment toxicity
- myelodysplastic syndrome
- acute myeloid leukemia
- out-of-pocket costs
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Havrilesky, L. J., Lim, S. L., Ehrisman, J. A., Lorenzo, A., Secord, A. A., Yang, J., Johnson, F. R., González, J. M., & Reed, S. D. (2020). Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment. Gynecologic Oncology, 156(3), 561–567. https://doi.org/10.1016/j.ygyno.2020.01.026
How many times has this paper been cited?
34 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Laura Jean Havrilesky, Stephanie L. Lim, Jessie A. Ehrisman, Amelia Lorenzo, Angeles Alvarez Secord, Jui‐Chen Yang, F. Reed Johnson, Juan Marcos González, Shelby D. Reed.
What is the DOI of this paper?
10.1016/j.ygyno.2020.01.026, permanently at https://doi.org/10.1016/j.ygyno.2020.01.026. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.